ONCO
NASD Onconetix Inc$0.6500 ↓ -0.0111 (-1.68%) Trading Down from the previous close of $0.6611
- YTD change
- -99.17%
- vs 20-day SMA
- -15.11%
- vs 200-day SMA
- -96.92%
Price ranges
Price & Performance
-0.63 (-48.75%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $90,950.0000
- ONCO is down 99% since the beginning of the year
- ONCO is down 100% over the past 12 months
- ONCO is down 23% over the past 1 month
- 3% of all ONCO investors are betting against ONCO
ONCO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -80.4%.
- Previous minute
- -$0.0150
- Last hour
- -$0.0150
- Last 5 days
- -20.73%
- vs 8-day SMA
- -20.66%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.